Loading...

Home
ETF
HRMY

HRMY

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

HRMY News

Avalo Therapeutics Appoints New Board Member

Jun 24 2026NASDAQ.COM

Paragon Biosciences Closes Sale of Emalex to Teva

Jun 11 2026Newsfilter

Bridge City Capital Fully Exits Harmony Biosciences Holdings

May 19 2026Fool

Bridge City Capital Fully Exits Harmony Biosciences Holdings

May 19 2026NASDAQ.COM

Harmony Biosciences Q1 2026 Earnings Call Insights

May 07 2026seekingalpha

Harmony Biosciences Q1 Earnings Miss Expectations

May 07 2026seekingalpha

Harmony Biosciences Reports 17% Revenue Growth in Q1 2026

May 07 2026Newsfilter

Harmony Biosciences Shares Rise on Patent Litigation News

Apr 21 2026seekingalpha

Harmony Biosciences Sues AET Pharma Over Patent Infringement

Apr 21 2026stocktwits

Wall Street Analysts Adjust Ratings

Feb 25 2026Benzinga

Harmony Biosciences Q4 2025 Earnings Highlights

Feb 24 2026seekingalpha

Harmony Biosciences Q4 Earnings Analysis

Feb 24 2026seekingalpha

Harmony Biosciences Reports $868.5 Million Revenue for 2025, Guidance for 2026 Exceeds $1 Billion

Feb 24 2026Newsfilter

Harmony Biosciences Downgraded, Shares Drop 10%

Feb 23 2026seekingalpha

Harmony Biosciences to Announce Q4 Earnings on February 24

Feb 23 2026seekingalpha

Harmony Biosciences Receives FDA Approval for Wakix Label Expansion

Feb 17 2026seekingalpha